CLINICAL_TRIALS
trial_result
· 2024-09-24
Clinical Trial Update: Erenumab for Idiosyncratic Facial Pain [Phase 4]
Summary
Phase 4 clinical trial results for erenumab in facial pain (with rhinosinusitis) have been completed and results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: David Jang, M.D. | Conditions: Facial Pain, Rhinosinusitis | Phase 4 | Status: COMPLETED | Results posted: 2024-09-24